Drug Approval | November 17, 2021
Alembic JV receives final approval for Mupirocin cream
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
This product will be manufactured at Lupin’s Pithampur facility In India
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
Subscribe To Our Newsletter & Stay Updated
